Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 28,700
+150 (0.53%)
At close: Mar 24, 2025, 3:30 PM KST
-24.67% (1Y)
| Market Cap | 1.53T |
| Revenue (ttm) | 138.94B |
| Net Income (ttm) | -1.80B |
| Shares Out | 50.77M |
| EPS (ttm) | -35.59 |
| PE Ratio | n/a |
| Forward PE | 151.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 396,474 |
| Average Volume | 568,763 |
| Open | 28,800 |
| Previous Close | 28,550 |
| Day's Range | 28,450 - 29,400 |
| 52-Week Range | 28,350 - 52,000 |
| Beta | 0.68 |
| RSI | 33.58 |
| Earnings Date | Mar 7, 2025 |